Return On Assets of Viking Therapeutics, Inc. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viking Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • Viking Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -28%, a 131% decline year-over-year.
  • Viking Therapeutics, Inc. annual Return On Assets for 2024 was -12%, a 56% increase from 2023.
  • Viking Therapeutics, Inc. annual Return On Assets for 2023 was -26%, a 32% increase from 2022.
  • Viking Therapeutics, Inc. annual Return On Assets for 2022 was -39%, a 62% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Viking Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -28% -16% -131% 01 Jul 2025 30 Sep 2025
Q2 2025 -19% -5% -33% 01 Apr 2025 30 Jun 2025
Q1 2025 -14% +4% +21% 01 Jan 2025 31 Mar 2025
Q4 2024 -12% +15% +56% 01 Oct 2024 31 Dec 2024
Q3 2024 -12% +17% +58% 01 Jul 2024 30 Sep 2024
Q2 2024 -15% +19% +57% 01 Apr 2024 30 Jun 2024
Q1 2024 -18% +26% +59% 01 Jan 2024 31 Mar 2024
Q4 2023 -26% +12% +32% 01 Oct 2023 31 Dec 2023
Q3 2023 -29% +3% +10% 01 Jul 2023 30 Sep 2023
Q2 2023 -33% -4% -15% 01 Apr 2023 30 Jun 2023
Q1 2023 -43% -17% -65% 01 Jan 2023 31 Mar 2023
Q4 2022 -39% -15% -62% 01 Oct 2022 31 Dec 2022
Q3 2022 -33% -11% -48% 01 Jul 2022 30 Sep 2022
Q2 2022 -29% -9% -48% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% -9% -56% 01 Jan 2022 31 Mar 2022
Q4 2021 -24% -9% -61% 01 Oct 2021 31 Dec 2021
Q3 2021 -22% -9% -68% 01 Jul 2021 30 Sep 2021
Q2 2021 -20% -8% -70% 01 Apr 2021 30 Jun 2021
Q1 2021 -17% -6% -58% 01 Jan 2021 31 Mar 2021
Q4 2020 -15% -6% -68% 01 Oct 2020 31 Dec 2020
Q3 2020 -13% -5% -65% 01 Jul 2020 30 Sep 2020
Q2 2020 -12% -3% -42% 01 Apr 2020 30 Jun 2020
Q1 2020 -11% -2% -20% 01 Jan 2020 31 Mar 2020
Q4 2019 -9% +2% +17% 01 Oct 2019 31 Dec 2019
Q3 2019 -8% +7% +48% 01 Jul 2019 30 Sep 2019
Q2 2019 -8% +24% +74% 01 Apr 2019 30 Jun 2019
Q1 2019 -9% +51% +85% 01 Jan 2019 31 Mar 2019
Q4 2018 -11% +119% +92% 01 Oct 2018 31 Dec 2018
Q3 2018 -15% +129% +90% 01 Jul 2018 30 Sep 2018
Q2 2018 -32% +87% +73% 01 Apr 2018 30 Jun 2018
Q1 2018 -59% +42% +41% 01 Jan 2018 31 Mar 2018
Q4 2017 -130% -35% -37% 01 Oct 2017 31 Dec 2017
Q3 2017 -144% -42% -41% 01 Jul 2017 30 Sep 2017
Q2 2017 -118% -14% -14% 01 Apr 2017 30 Jun 2017
Q1 2017 -101% +21% +17% 01 Jan 2017 31 Mar 2017
Q4 2016 -95% +63% +40% 01 Oct 2016 31 Dec 2016
Q3 2016 -103% +41% +29% 01 Jul 2016 30 Sep 2016
Q2 2016 -104% 01 Apr 2016 30 Jun 2016
Q1 2016 -123% 01 Jan 2016 31 Mar 2016
Q4 2015 -157% 01 Oct 2015 31 Dec 2015
Q3 2015 -144% 01 Jul 2015 30 Sep 2015

Viking Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -12% +15% +56% 01 Jan 2024 31 Dec 2024
2023 -26% +12% +32% 01 Jan 2023 31 Dec 2023
2022 -39% -15% -62% 01 Jan 2022 31 Dec 2022
2021 -24% -9% -61% 01 Jan 2021 31 Dec 2021
2020 -15% -6% -68% 01 Jan 2020 31 Dec 2020
2019 -9% +2% +17% 01 Jan 2019 31 Dec 2019
2018 -11% +119% +92% 01 Jan 2018 31 Dec 2018
2017 -130% -35% -37% 01 Jan 2017 31 Dec 2017
2016 -95% +63% +40% 01 Jan 2016 31 Dec 2016
2015 -157% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.